Patrick Stephen Gallagher - Feb 15, 2023 Form 4 Insider Report for Sensei Biotherapeutics, Inc. (SNSE)

Role
Chief Business Officer
Signature
/s/ Mark Ballantyne, Attorney-in-Fact
Stock symbol
SNSE
Transactions as of
Feb 15, 2023
Transactions value $
-$14,075
Form type
4
Date filed
9/11/2023, 05:34 PM
Previous filing
Jun 3, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SNSE Common Stock Tax liability -$14.1K -9.38K -21.56% $1.50 34.1K Feb 15, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Patrick Stephen Gallagher is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock units.